The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

Zdravko Mitrovic, Martin Bast, Philip J. Bierman, Robert G. Bociek, Julie M. Vose, Wing C. Chan, James O. Armitage

Research output: Contribution to journalLetter

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)401-403
Number of pages3
JournalBritish Journal of Haematology
Volume157
Issue number3
DOIs
StatePublished - May 2012

Keywords

  • Diffuse large B-cell lymphoma
  • Non-Hodgkin lymphoma
  • Relapse
  • Rituximab
  • Secondary central nervous system lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this